Cellebrite DI (CLBT) Shares Outstanding (Diluted Average) (2019 - 2025)

Cellebrite DI's Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $249.9 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Diluted Average) rose 19.3% year-over-year to $249.9 million; the TTM figure through Dec 2025 stood at $249.9 million (up 19.3% YoY), while the FY2025 annual figure was $310000.0, down 77.04% from the prior year.
• Shares Outstanding (Diluted Average) was $249.9 million for Q4 2025 at Cellebrite DI, up from $230000.0 in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $249.9 million in Q4 2025 to a low of $1000.0 in Q1 2021.
• Historically, Shares Outstanding (Diluted Average) has averaged $60.8 million across 5 years, with a median of $405000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) jumped 36398.99% in 2023, then tumbled 99.27% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $161.5 million in 2021, then advanced by 20.96% to $195.4 million in 2022, then dropped by 2.68% to $190.2 million in 2023, then climbed by 10.16% to $209.5 million in 2024, then advanced by 19.3% to $249.9 million in 2025.
• The last three Shares Outstanding (Diluted Average) figures came in at $249.9 million (Q4 2025), $230000.0 (Q3 2025), and $150000.0 (Q2 2025), per Business Quant data.